Jorge Ferreira

TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE‐ACS

Pedro de Araújo Gonçalves, Jorge Ferreira, Carlos Aguíar et al. · European Heart Journal · 2005 · 521 citations · Full text

Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease

Marc S. Sabatine, Gaetano Maria De Ferrari, Robert P. Giugliano et al. · Circulation · 2018 · 248 citations · Full text

The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study

Stuart J. Connolly, Lars Wallentin, Michael D. Ezekowitz et al. · Circulation · 2013 · 218 citations

Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin

Robert P. Giugliano, Anthony Keech, Sabina A. Murphy et al. · JAMA Cardiology · 2017 · 103 citations · Full text

Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial

A. Michael Lincoff, Matthew T. Roe, Philip E. Aylward et al. · European Heart Journal · 2014 · 101 citations · Full text